A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2002
12/18/2002	EP1265616A2 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP1265596A2 Medical emulsion for lubrication and delivery of drugs
12/18/2002	EP1086101B1 Beta-carboline compounds
12/18/2002	EP1079833A4 Cocaine receptor binding ligands
12/18/2002	EP0946721B1 Human growth gene and short stature gene region
12/18/2002	EP0930889B1 CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
12/18/2002	EP0925503B1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity
12/18/2002	EP0873309B1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
12/18/2002	CN1385436A Alpha-heterosidase inhibitor and use thereof
12/18/2002	CN1385421A Novel alpha-amino acid compound, its preparation process and medicinal composition contaiing same
12/18/2002	CN1385413A Composition containing conjugated calcium linoleate and making method thereof
12/18/2002	CN1385210A Process for preparing Chinese medicine stasis-removing and fat-reducing pill
12/18/2002	CN1385196A Multi-function health care food and application thereof
12/18/2002	CN1385188A Method for extracting and separating effective part from dogbane
12/18/2002	CN1385172A Capsule for treating diabetes and productive method thereof
12/18/2002	CN1385170A Natural propolis nutrient liquor and process for preparing same
12/18/2002	CN1385169A Medicine composition for treating diabetes
12/18/2002	CN1385158A Application of hederagenin in preparing anihyperlipemia medicine
12/18/2002	CN1385109A High-efficient fat reducing and I, II type glyenresis patient staple food and preparation method thereof
12/17/2002	US6495684 Inhibit human factor xa; treating diseases characterized by thrombotic activity; for example 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4-(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine
12/17/2002	US6495589 An amino acid derivative useful to increase secretion of growth hormone (gh) from the anterior pituitary of mammals, including on sustained release basis
12/17/2002	US6495587 Tricyclic indole-2-carboxylic acid compound used as NMDA receptor antagonist
12/17/2002	US6495582 Erk (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
12/17/2002	US6495581 Drug for treating diabetes mellitus, hyperlipemia, impaired glucose tolerance, arterial sclerosis and improving insulin resistance, inflammatory disease
12/17/2002	US6495574 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
12/17/2002	US6495570 Combination drug therapy for glycolipid storage diseases
12/17/2002	US6495559 For therapy of obesity
12/17/2002	US6495556 Treating leukemia and lymphoma, sunburn and skin cancer
12/17/2002	US6495555 Tricyclic Δ-3-piperidines as α2-antagonists
12/17/2002	US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
12/17/2002	US6495546 Propanolamine derivatives
12/17/2002	US6495544 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
12/17/2002	US6495543 Treating or preventing melatoninergic disorders
12/17/2002	US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome
12/17/2002	US6495541 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/17/2002	US6495533 Drugs containing phosphoric acid derivatives as the active ingredient
12/17/2002	US6495525 N-((4-(((2-methylphenylamino)carbonyl)amino)phenyl)acetyl)-l -prolyl-3-methyl)-beta-alanine; very late antigen-4 cell adhesion inhibitor; inflammation and immune reactions
12/17/2002	US6495522 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
12/17/2002	US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein
12/17/2002	US6495173 Administering yeasts, coenzyme q10 and tocopherols as antilipemic agents for prevention of cardiovascular disorders
12/17/2002	US6495162 Controlled release oral tablet having a unitary core
12/17/2002	CA2131822C Use of estriol for treating climacteric osteoporosis
12/17/2002	CA2062091C Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
12/14/2002	CA2390686A1 Cofactor-based screening method for nuclear receptor modulators and related modulators
12/13/2002	WO2001096575A1 Ceramide kinase and dna encoding the same
12/13/2002	CA2412876A1 Ceramide kinase and dna encoding the same
12/12/2002	WO2002099115A2 Nucleic acid-associated proteins
12/12/2002	WO2002099026A1 Methods and formulations for enhancing the dissolution of a solid material in liquid
12/12/2002	WO2002098893A1 Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
12/12/2002	WO2002098880A1 5-ethyl-imidazotriazinones
12/12/2002	WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	WO2002098872A1 Isoindolines and process for preparation thereof
12/12/2002	WO2002098871A1 Phenylcarboxamides and process for preparation thereof
12/12/2002	WO2002098869A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds
12/12/2002	WO2002098865A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/12/2002	WO2002098863A1 Fused imidazole derivative
12/12/2002	WO2002098857A1 New indole derivatives with 5-ht6 receptor affinity
12/12/2002	WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	WO2002098840A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
12/12/2002	WO2002098839A1 Biphenylcarboxamides and process for preparation thereof
12/12/2002	WO2002098510A1 Combination of a ptpase inhibitor and an aldose reductase inhibitor
12/12/2002	WO2002098444A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
12/12/2002	WO2002098440A1 Drugs for diabetes
12/12/2002	WO2002098438A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
12/12/2002	WO2002098437A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002	WO2002098436A1 Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
12/12/2002	WO2002098431A1 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
12/12/2002	WO2002098429A1 Ethanolamine, diethanolamine or triethanolamine salt of zopolrestat
12/12/2002	WO2002098413A2 Pharmaceutical compositions comprising orlistat and fatty acids and/or salts thereof
12/12/2002	WO2002098410A1 Combination of a ptpase inhibitor and a sulfonylurea agent
12/12/2002	WO2002098409A1 Combination therapy for type ii diabetes or syndrome x
12/12/2002	WO2002098408A1 Ptpase inhibitors for improving cardiovascular risk profile
12/12/2002	WO2002098407A1 COMBINATION OF A PTPase INHIBITOR AND AN ALPHA-GLUCOSIDASE INHIBITOR
12/12/2002	WO2002098353A2 Compositions and methods for inhibiting bone resorption
12/12/2002	WO2002098348A2 Glp-1 formulations with protracted time action
12/12/2002	WO2002098242A1 Calorically dense liquid oral supplement
12/12/2002	WO2002098232A1 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002	WO2002089848A3 Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes
12/12/2002	WO2002085306A3 Use of follistatin to increase muscle mass
12/12/2002	WO2002072078A3 Use of sugar phosphates, amino acids, amino acid analogs, e.g. carbomethoxypropionyl cyanide for reducing weight or diabetes complications
12/12/2002	WO2002068015A9 Modular infusion device and method
12/12/2002	WO2002066458A3 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
12/12/2002	WO2002065989A3 Aminoglycoside treatment for lysosomal storage diseases
12/12/2002	WO2002064543A3 Novel succinate salt of o-desmethyl-venlafaxine
12/12/2002	WO2002062297A9 Methods and compositions for modulating gluconeogenesis using pgc-1
12/12/2002	WO2002061052A3 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
12/12/2002	WO2002056852A9 Cosmetics
12/12/2002	WO2002029044A3 Modulation of the transcription of pro-inflammatory gene products
12/12/2002	WO2001054731A3 Ligand conjugates and methods for preparing same
12/12/2002	WO2001018207A9 Human 7tm proteins receptors and polynucleotides encoding the same
12/12/2002	US20020188139 P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparartion and use
12/12/2002	US20020188133 Producing an isoxazolidinedione compound from beta - methyl L-aspartate via an important intermediate oxazolylethanol derivative
12/12/2002	US20020188124 Novel spiro compounds
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188107 Plant protein for use in the treatment of cancer
12/12/2002	US20020188029 Methods of treating or preventing weight gain, obesity, and related disorders
12/12/2002	US20020188018 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/12/2002	US20020188015 Method and composition for rejuvinating cells, tissues organs, hair and nails
12/12/2002	US20020188007 Pyrazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them

1 ... 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 ... 1298